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Proteins prone to misfolding form large macroscopic
deposits in many neurodegenerative diseases. Yet
the in situ aggregation kinetics remains poorly under-
stood because of an inability to demarcate precursor
oligomers from monomers. We developed a strategy
for mapping the localization of soluble oligomers and
monomers directly in live cells. Sensors for mutant
huntingtin, which forms aggregates in Huntington’s
disease, were made by introducing a tetracysteine
motif into huntingtin that becomes occluded from
binding biarsenical fluorophores in oligomers, but
not monomers. Up to 70% of the diffusely distributed
huntingtin molecules appeared as submicroscopic
oligomers in individual neuroblastoma cells express-
ing mutant huntingtin. We anticipate the sensors to
enable insight into cellular mechanisms mediated
by oligomers and monomers and for the approach
to be adaptable more generally in the study of protein
self-association.
INTRODUCTION
The misfolding of proteins into macroscopic aggregates such as
plaques and inclusion bodies is a hallmark of Alzheimer’s,
Creutzfeldt-Jakob, Huntington’s, and other neurodegenerative
diseases (Chiti and Dobson, 2006). However, the role of aggre-
gation, per se, in disease is controversial. Indeed, in many of
these diseases, notably Huntington’s, Alzheimer’s, and Parkin-
son’s, small soluble oligomers or other diffuse forms, which
may be precursors to the macroscopic aggregates, seem to
correlate best with cellular dysfunction (Arrasate et al., 2004;
Haass and Selkoe, 2007). Despite evidence that soluble oligo-
mers are more toxic than the macroscopic aggregates, quantita-
tive assessment of the formation of the earliest, submicroscopic
oligomers in live cells is limited by the lack of suitable tools.
To overcome these limitations, we developed a novel approachChemistry & Biology 17,to rapidly distinguish monomers from all other soluble aggre-
gates directly in live cells.
Our approach centers on the mutant exon 1 fragment of
huntingtin (Httex1), which has been used extensively to model
Huntington’s disease in transgenic mice, mammalian cells,
Drosophila melanogaster, yeast, and Caenorhabditis elegans
(Brignull et al., 2006; Duennwald et al., 2006; Jackson et al.,
1998; Mangiarini et al., 1996). Huntington’s disease is caused
by CAG codon duplications in the Htt gene that translate into
an abnormally long polyglutamine (polyQ) sequence near the
N terminus of the protein (MacDonald et al., 1993). The patho-
genic polyQ expansions cause Htt to aggregate and redistribute
from a diffuse cytosolic pool into inclusion bodies during disease
progression. Normally Htt has 7–36 glutamines in the polyQ
repeat, while in disease there are 37 or more (MacDonald et al.,
1993). The number of glutamines beyond this threshold is highly
correlated with earlier onset of disease and the rate of protein
aggregation (Chen et al., 2001; Perutz et al., 1994; Scherzinger
et al., 1999). PolyQ expansions have been described in at least
eight unrelated proteins that also cause disease, suggesting
that aggregation of polyQ is concomitant with cellular dysfunc-
tion more generally (Zoghbi and Orr, 2000).
Our approach to distinguish Httex1 monomers from other olig-
omers relies on genetically tagging the protein with two labels.
The first is Cerulean, a brighter, cyan-fluorescent variant of
enhanced green fluorescent protein (EGFP) (Rizzo et al., 2004)
that detects Httex1 localization. Httex1 fused to EGFP has been
used to report on polyQ-dependent inclusion body formation
and key cellular toxicities associated with that process (Arrasate
et al., 2004; Bennett et al., 2007). The second is a tetracysteine
(TC) motif, Cys-Cys-Pro-Gly-Cys-Cys, that binds with high
affinity (nanomolar dissociation constant) and specificity to the
cell-permeable biarsenical dyes FlAsH and ReAsH (Adams
et al., 2002). Upon binding to a TC motif, FlAsH (green fluores-
cence) and ReAsH (red fluorescence) increase in fluorescence
up to 50,000-fold; in the unbound state, the dyes are essentially
nonfluorescent (Adams et al., 2002).
Developed as small, and hence less structurally disruptive,
alternatives to fluorescent proteins, TC tags and biarsenical
dyes have also been used to report on protein folding and
conformational changes (Coleman et al., 2009; Ignatova and371–379, April 23, 2010 ª2010 Elsevier Ltd All rights reserved 371
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Figure 1. Strategy for Using TC Tags to Demarcate
Htt Oligomers from Monomers
(A) The quantity of all forms of Httex1 is determined from
Cerulean fluorescence. ReAsH binding shows whether
Httex1-Cerulean is aggregated or monomeric.
(B) Schematic of the placement of the TC tags within the
Httex1-Cerulean sequence and the sequence of the TC
insertions. The exact sequence locations are described
in detail in Figure S1.
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Demarcation of Htt Oligomers from MonomersGierasch, 2004; Luedtke et al., 2007; Roberti et al., 2007).
We devised a novel adaptation of the TC motif so that the
conversion of Httex1 monomer into oligomers rendered the TC
tag inaccessible to ReAsH. We extended this approach to other
color combinations by using Httex1 fused to the red fluorescent
protein Cherry to track Httex1 localization and the use of FlAsH
to selectively label the monomeric forms of Httex1. Hence, two-
color fluorescence detection for ReAsH reactivity (red) and Ceru-
lean (cyan) or the alternative pair of FlAsH reactivity (green) and
Cherry (red) enabled the quantitative monitoring of protein oligo-
merization directly in situ. Here we describe the development
and validation of the approach and its use to visually distinguish
monomers from all other oligomers of Htt within living cells.RESULTS
Development of the Initial Generation of Markers
A single TC tag was initially inserted into the Httex1-Cerulean
sequence at various locations with the goal of identifying
sequence positions in which TC was exposed in Httex1-Cerulean
monomers and buried in oligomers. Because high-resolution
structures of Httex1 are not available, we used a systematic scan-
ning approach guided by known conformational properties of
Httex1. Httex1 monomers sample a series of compact and non-
compact conformations with little stable secondary structure,
but the polyQ region is predicted to form a highly stable, com-
pact b sheet core in aggregated Htt (Bennett et al., 2002; Crick
et al., 2006; Dougan et al., 2009; Perutz et al., 1994). Thus, TC
tags inserted near the polyQ region are likely to bind biarsenical
dyes in the monomer due to the high solvent accessibility but be
inaccessible in oligomers and larger aggregates (Figure 1A).
Hence, in our first generation of variants, the TC tag was placed
at the junction of Htt and Cerulean (TC1), within the proline-rich
region of Htt (TC2), or at the N terminus of the polyQ repeat
sequence (TC3) (Figure 1B; see Figure S1A available online).
To test TC1–3 as aggregation reporters, we expressed and
purified the recombinant proteins from Escherichia coli using a
pathogenic polyQ length (Httex1
46Q) that readily forms amyloid-
like fibrils in vitro (Scherzinger et al., 1999). To regulate the rate
of aggregation in vitro, we fused Httex1
46Q-Cerulean to the372 Chemistry & Biology 17, 371–379, April 23, 2010 ª2010 Elsevierre
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inhibited aggregation in a manner similar to
that of Httex1 fused to glutathione S-transferase
(Schaffar et al., 2004; Scherzinger et al., 1999)
(Figure 2A). Tobacco etch virus (TEV) protease
liberated monomeric Httex1
46Q-Cerulean, which
over time formed aggregates that were insoluble
in sodium dodecyl sulfate (SDS) (Figure 2A).To validate Cerulean as a robust indicator of protein levels
gardless of aggregation status, we assessed its fluorescence
soluble protein (monomer) and aggregated states. We found
o difference (Figures S2A–S2C), consistent with the ability of
GFP, which is similar to Cerulean in structure and sequence,
report on Httex1 quantity in cells (Arrasate et al., 2004).
Next, we determined whether the soluble protein or aggre-
ates of each variant of Httex1
46Q-Cerulean could bind to ReAsH
a native slot blot assay. In this assay, recombinant protein in
ondenaturing buffers becomes affixed to a nitrocellulose
embrane, while unbound ReAsH passes through (Figure 2B).
ttex1
46Q-Cerulean soluble protein and aggregates without the
C tag bound to the membrane as assessed by Cerulean fluo-
scence, and ReAsH did not bind appreciably. In contrast, all
C-tagged Httex1
46Q-Cerulean soluble protein bound to ReAsH
igure 2B). TC1- and TC2-Httex1
46Q-Cerulean also bound to Re-
sH in the aggregated forms, but TC3-Httex1
46Q-Cerulean bound
oorly, which suggests that TC3 is inaccessible to ReAsH upon
ggregation (Figure 1A).
To verify that TC3 reports on aggregation without perturbing
e conformation and aggregation potential, we examined
e aggregates by negative-staining electron microscopy. The
brillar architecture of the TC1–3 variants and the non-TC-
gged forms were similar (Figure S3). In an assay monitoring
e quantity of pelleted protein, the kinetics of fibril formation
ere also similar for TC3-Httex1
46Q-Cerulean and the non-TC
ounterpart (Figure 3A). Thus, the TC tags have little, if any, influ-
nce on the core aggregation properties of Httex1
46Q-Cerulean
to amyloid-like fibrils.
We next assessed the ability of TC3 to report on the aggrega-
on kinetics of Httex1-Cerulean, as judged by ReAsH reactivity
igure 3B). TC3 ReAsH reactivity decreased as the quantity of
elleted aggregates increased, indicating that TC3 demarcates
oluble protein from aggregates in constructs of variable polyQ
ngth (Figure 3B).
plementation of the Initial TC Constructs
Living Cells
o determine whether the TC3 reporter distinguishes monomers
om oligomers in live neuroblastoma (Neuro2a) cells (Fig-
ure 4A), we assessed in situ ReAsH reactivity with TC3 inrved
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Figure 2. Screening Recombinant Httex1-Cerulean for ReAsH Reactivity in Monomers versus Aggregates
(A) Fusion of Httex1-Cerulean to maltose-binding protein (MBP) suppressed aggregation. Aggregation was induced by liberation of MBP with TEV protease, and
the efficiency of cleavage was assessed by SDS-PAGE. Aggregates were identified by their insolubility in SDS.
(B) Native slot blots to screen TC-tagged forms of Httex1
46Q-Cerulean for aggregation-dependent ReAsH reactivity. The binding of protein was revealed by
Cerulean fluorescence and ReAsH reactivity by ReAsH fluorescence.
(C) Native slot blots to screen for aggregation and polyQ length dependency of ReAsH reactivity for TC1-, TC9-, and TC10-tagged Httex1-Cerulean.
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Demarcation of Htt Oligomers from MonomersHttex1
25Q-Cerulean, which has a subpathogenic polyQ length.
Untagged (control) Httex1
25Q-Cerulean had a diffuse, cytosolic
distribution with no ReAsH fluorescence and no inclusion
bodies. The TC1 counterpart had an identical phenotype but
had substantial ReAsH reactivity. In contrast, TC3-Httex1
25Q-
Cerulean was unexpectedly distributed into small globular struc-
tures that bound poorly to ReAsH (Figure 4A). TC3-Httex1
46Q-
Cerulean was also distributed into small globular structures,
whereas the TC1 and the non-tagged counterparts formed
inclusion bodies in many cells, consistent with the expected
behavior of the 46Q context (Arrasate et al., 2004).Incubation Time (h)
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Chemistry & Biology 17,The first 18 residues of Htt are critical for its cellular localization
and targeting to the endoplasmic reticulum and mitochondria
(Atwal et al., 2007; Rockabrand et al., 2007; Steffan et al.,
2004). Since TC3 lies between residues 17 and 18 of Httex1,
our data suggest that TC3 disrupts normal interactions with
cellular components and ligands through this motif. Yet while
the kinetics studies of recombinant protein (Figure 3) suggested
that this defect is independent of its intrinsic aggregation proper-
ties, we cannot exclude the possibility that TC3 changed the
aggregation potential of the polyQ sequence in the cellular envi-
ronment. Indeed, a recent study implicated the first 17 residues 
 TC
Incubation Time (h)
0 20 40 60 80 100
Figure 3. TC3 Reports on Httex1 Aggrega-
tion State In Vitro with No Detectable Alter-
ations in Aggregation Properties
(A) Recombinant TC3-Httex1
46Q-Cerulean aggre-
gates at a rate similar to that of untagged
Httex1
46Q-Cerulean; thus, the tag does not inter-
fere with the intrinsic aggregation potential.
(B) PolyQ length dependency of TC3-Httex1-Ceru-
lean aggregation rates correlates with the extent
of ReAsH reactivity, indicating that TC3 does not
bind to ReAsH when Httex1-Cerulean forms aggre-
gates. Cerulean-TC is shown as a non-aggre-
gating control, indicating that a TC motif remains
available for ReAsH binding throughout the
duration of the experiment. Values are mean ±
SD (n = 3).
371–379, April 23, 2010 ª2010 Elsevier Ltd All rights reserved 373
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ReAsH
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A 25Q No TC 25Q TC1 25Q TC3
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B 25Q 46Q
Figure 4. TC3 Interferes with Httex1-Ceru-
lean Cellular Localization but Not the In-
Cell Aggregation Potential
(A) TC1-Httex1
25Q-Cerulean and the non-TC coun-
terpart have a diffuse cytosolic localization in neu-
ro2a cells and bind ReAsH in a TC-dependent
manner. TC3- Httex1
25Q-Cerulean is expressed at
much lower levels and has a granular distribution,
indicating aberrant localization and/or trafficking.
The same phenotype was observed in cells
expressing TC3-Httex1
46Q-Cerulean.
(B) Expression of TC3-polyQ and TC5-polyQ
lacking other Htt-specific sequences in neuro2a
cells. TC3-25Q-GFP and TC3-46Q-GFP dis-
played aggregation and localization phenotypes
identical to those of their non-TC counterparts.
In contrast, TC5-25Q-GFP formed inclusions,
indicating that polyQ linkers can enhance the
in-cell aggregation potential when juxtaposed
N-terminally to the TC3 tag. Scale bars, 50 mm.
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Demarcation of Htt Oligomers from Monomersas important in modulating aggregation rates (Thakur et al.,
2009).
Hence, to further investigate the cause of this defect, we intro-
duced TC3 into polyQ25-EGFP and polyQ46-EGFP, which lack
Htt-specific sequences other than the polyQ sequence (Fig-
ure S1B). TC3 did not influence the localization or inclusion
body formation of polyQ25- or polyQ46-EGFP, confirming that
TC3 does not intrinsically alter aggregation in cells (Figure 4B).
Additionally, ReAsH bound readily to the TC3-polyQ-EGFP con-
structs, suggesting that TC3 can be adapted to other polyQ-
containing proteins.
Refinement of TC3 to Prevent Htt Cellular
Localization Defects
To prevent the defects TC3 causes in Httex1-Cerulean, we initially
tried two approaches. First, since a TC tag reports on oligomer-
ization when juxtaposed to the N terminus of polyQ and might
also do so when juxtaposed to the C terminus, we shifted the
TC tag outside the first 18 residues of Htt (Figure 1B, TC4).
However, in the native slot blot assay, there was no difference
in ReAsH reactivity between soluble protein and aggregates of
recombinant TC4-Httex1
46Q-Cerulean (Figure 2B).
Second, we retained the position of TC3 but inserted a new
polyQ6 linker sequence immediately N-terminal to the TC tag
to restore the 18 residue homology of Htt (Figure 1B, TC5).
Recombinant TC5-Httex1
46Q-Cerulean showed a marked
decrease in ReAsH reactivity from soluble protein to aggregate
in the native slot blot assay, providing confidence that this374 Chemistry & Biology 17, 371–379, April 23, 2010 ª2010 Elseviera
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In neuro2a cells, TC5-Httex1
25Q-Cerulean
had a mostly normal cellular distribution;
however, approximately 25% cells also
displayed a more punctate cellular dis-
tribution, suggesting that the linker did
not fully rescue the defects of TC3
(Figure S4A).
Next, we extended the linker sequence
before TC3 from 6Q in TC5 to 11Q (TC6),polyQ repeat length comparable to the shortest natural variants
human Htt (Zuhlke et al., 1993) (Figure 1B). To our surprise,
C6-Httex1
25Q-Cerulean, which has an 11Q sequence followed
y the TC tag and endogenous 25Q sequence, formed inclusion
odies in many cells (Figure S4A), perhaps because the new
olyQ sequence N-terminal to TC3 increases the aggregation
otential of the endogenous polyQ sequence. To determine if
e enhanced inclusion body formation was independent of
ttex1-specific trafficking defects caused by TC3, we introduced
C5 into polyQ25-EGFP. TC5-polyQ25-EGFP had a phenotype
imilar to that of TC5 in the Httex1-Cerulean context, confirming
at the enhanced aggregation is independent of the localization
efects (Figure 4B).
We also investigated whether shortening the linker would
duce the aggregation potential without causing mislocalization
wo or five glutamines; Figure 1B, TC7 and TC8, respectively).
C7 displayed the same defect as TC3, indicating that at least
e first 19 residues of Htt are necessary for normal cellular local-
ation; however, TC8-Httex1
25Q-Cerulean was mostly normally
istributed, but over time did form punctate aggregates, albeit
a lesser extent than TC5 and TC6 (Figure S4A).
Nuclear magnetic resonance studies have shown that a TC tag
rms a b hairpin centered around the Pro-Gly residues when
omplexed to ReAsH, suggesting that TC tags stabilize a polyQ
airpin configuration that favors aggregation (Madani et al.,
009). Repeating short polyQ sequences separated by Pro-Gly
hairpins synergistically promote aggregation to a similar or
reater extent than the contiguous polyQ sequence lacking the
ACB
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Figure 5. TC9 and TC10 Bind ReAsH Only in Htt
Monomers In Vitro with No Detectable Alterations
in Aggregation Properties
(A) TC1-, TC9-, and TC10-Httex1-Cerulean in the 46Q and
25Q contexts had the same rates of aggregation as their
non-TC counterparts when assessed by amount of pel-
leted material by centrifugation. Thus, the tags do not per-
turb the intrinsic aggregation potential of Httex1. ReAsH
reactivity of TC9- and TC10-Httex1
46Q-Cerulean also
correlated with the proportion of non-pelleted material
in a microcentrifuge assay, indicating that these tags
report on aggregation. In contrast, TC1-Httex1
46Q-Ceru-
lean showed no decrease or correlation of ReAsH reac-
tivity with non-pelleted material, indicating the ability to
bind ReAsH in monomers and aggregates equivalently.
Values are mean ± SD (n = 3).
(B) TC9- and TC10-Httex1-Cerulean had the same fibrillar
morphology as their non-TC counterparts, as assessed
by negative-staining electron microscopy. Scale bars,
100 nm.
(C) Gel-filtration chromatography of TC1-, TC9-, and
TC10-Httex1
46Q-Cerulean after 6 hr of incubation. The
predominant species eluted at 9.5 ml and likely corre-
sponds to monomers; a small peak at 7 ml corresponds
to soluble aggregates. The insets show magnified regions
corresponding to the void volume. Arrows point to the
elution volume of the proteins indicated above them.
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Demarcation of Htt Oligomers from Monomersb hairpins (Thakur and Wetzel, 2002). Conversely, aggregation is
inhibited when the Pro-Gly b hairpins are replaced with a single
Pro residue, which by itself destabilizes configurations favorable
for aggregation (Thakur and Wetzel, 2002). To inhibit this mode of
TC-facilitated aggregation, we inserted a polyQ linker necessary
for proper Htt trafficking (5Q) flanked at the C terminus by a single
Pro, immediately N-terminal to the TC3 tag (Figure 1B, TC9).
We also examined a construct containing a tandem polyQ5-
proline-polyQ4-proline immediately N-terminal to the TC3 tag
(Figure 1B, TC10). In neuro2a cells, both TC9- and TC10-
Httex1-Cerulean showed a normal cellular distribution indistin-
guishable from that of untagged versions for both the 25Q
and 46Q contexts, indicating that we had both rescued the
localization defect and prevented TC-facilitated aggregation
(Figure S4B).
To validate TC9 and TC10 as aggregation reporters, we exam-
ined recombinant TC9- and TC10-Httex1-Cerulean for ReAsH
reactivity of soluble protein versus aggregates in the native slot
blot assay. TC9 and TC10 bound ReAsH in soluble protein
(25Q and 46Q) but bound ReAsH poorly as aggregates (46Q)Chemistry & Biology 17, 371–379, April 23(Figure 2C). TC9 and TC10 also tracked Htt
aggregation kinetics by ReAsH reactivity,
whereas TC1, whose ReAsH reactivity is insen-
sitive to aggregation state, did not (Figure 5A).
TC9 and TC10 did not influence aggregate
morphology (Figures 5A and 5B). Furthermore,
TC1 and TC9 reported on aggregation sim-
ilarly with the green fluorescent biarsenical
dye FlAsH, indicating that both of the most
commonly used biarsenical dyes can be
used to demarcate monomers from oligomers
(Figure S5).To determine precisely which oligomeric forms of TC9- and
TC10-Httex1
46Q-Cerulean bind ReAsH, we subjected recombi-
nant TC1-, TC9-, and TC10-tagged Httex1
46Q-Cerulean to
gel-filtration chromatography. After a 6 hr aggregation, the inter-
mediate time point for aggregation kinetics, approximately
5%–10% of Httex1
46Q-Cerulean, consisted of material that
pelleted by centrifugation (Figure 5A). Low-speed pelleting
(1500 3 g, 5 min) was used to remove the largest aggregates
that cannot traverse the Superdex 75 column, and the remaining
soluble material was assessed for oligomeric size. The predom-
inant species eluted at a time point consistent with the monomer
(Figure 5C). However, a small amount of higher-mass material
was found in the void volume, which likely comprises non-pel-
leted oligomers or material that had self-associated during the
chromatography fractionation. Fractions corresponding to
eluted protein were assessed for ReAsH reactivity and the
TC1, TC9, and TC10 monomer fractions all bound ReAsH. In
contrast, only TC1-tagged Httex1
46Q-Cerulean eluting in the
void volume bound ReAsH. The absence of TC9 and TC10
binding to the oligomers in the void volume indicates that the, 2010 ª2010 Elsevier Ltd All rights reserved 375
ReAsH
Overlay
Cerulean
46Q
TC9TC1No TC TC10
Figure 6. Assessment of TC Tag Reactivity and
Detection of Httex1 Aggregation State within Inclu-
sions
The fluorescence of ReAsH and Cerulean is scaled to
emphasize the inclusions (the fluorescence for the other
cellular regions are too dim to see). Scale bar, 10 mm.
The same images are shown at a lower magnification in
Figure S6.
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Demarcation of Htt Oligomers from Monomerssmallest detectable aggregates cannot bind ReAsH. This finding
supports the conclusion that TC9 and TC10 binds ReAsH only in
monomers, whereas TC1 binds ReAsH similarly in monomers,
oligomers, and pelleted aggregates (Figure 5C).
The TC1, TC9, and TC10 constructs were used to examine
the extent of aggregation of Httex1-Cerulean in neuro2a cells.ReAsH
Overlay
Cerulean
25Q
TC9TC1No TC TC10 No TC
Figure 7. In-Cell Demarcation of Monomers from Oligomers of Htt in Cellular Regions o
Images were acquired with the dynamic range adjusted to quantify cytosolic Httex1-Cerulean outside in
than the dynamic range of detection and are excluded in the overlay images. Also excluded is Cerulea
ground level. Scale bars, 25 mm. The insets show the selected cells at higher resolution.
376 Chemistry & Biology 17, 371–379, April 23, 2010 ª2010 Elsevier Ltd All rights reseWe first focused on inclusion bodies formed
by Httex1
46Q-Cerulean (Figure 6). TC9 and
TC10 showed far less ReAsH reactivity than
TC1, which is consistent with inclusion bodies
consisting primarily of aggregates (Kim et al.,
2002). In Httex1
25Q-Cerulean, TC1, TC9, and
TC10 all bound ReAsH similarly as indicated
by tight colocalization of Cerulean and ReAsH
fluorescence intensities, consistent with all
tags being accessible to bind ReAsH and
a lack of oligomers in the cytosol (Figure 7).We next focused on the cytosolic pool of Httex1
46Q-Cerulean.
TC1 bound ReAsH to about the same extent as it did in Httex1
25Q-
Cerulean (Figure 7). In contrast, TC9 and TC10 showed markedly
less ReAsH reactivity than TC1 in the context of Httex1
46Q-Ceru-
lean and TC9 and TC10 in the context of Httex1
25Q-Cerulean
(Figure 7). Thus, the diffuse pool of cytosolic Httex1
46Q-Cerulean46Q
TC9TC1 TC10
utside of Inclusion Bodies
clusion bodies. Note that the inclusion bodies are brighter
n fluorescence intensity lower than three times the back-
rved
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oligomers that are otherwise not visible by confocal microscopy.
Analysis of pixel intensity correlation plots and ReAsH fluores-
cence standardized to the Cerulean fluorescence intensity
indicated that the binding of ReAsH to cytosolic TC9- and
TC10-Httex1
46Q was approximately 50%–70% less than the
binding of ReAsH to TC9- and TC10-Httex1
25Q-Cerulean in indi-
vidual cells (Figure S7A).
We also examined whether FlAsH could be similarly used to
report on aggregation in live cells. While FlAsH did bind to
TC1- and TC9-Httex1-Cerulean, data was difficult to interpret
due to a highly efficient FRET from Cerulean to bound FlAsH.
Hence, while FRET may have a useful application in the study
of Htt conformations, it hinders the utility of Cerulean as an inde-
pendent marker of protein localization and concentration.
To further explore the use of FlAsH to report on Httex1 aggrega-
tion, we replaced the Cerulean moiety with the monomeric red
fluorescent protein Cherry. The Cherry/FlAsH labeling combina-
tion produced the same result as the Cerulean/ReAsH, validating
its use as an alternative spectral toolset for imaging (Figure S7B).
Examination of cell-cell differences in ReAsH (or FlAsH) reactivity
using the TC9- and TC10-Httex1
46Q-Cerulean (or Cherry) sug-
gested that different cells have different proportions of cytosolic
aggregate/monomer content. In several cells that contained
a small inclusion body, overall biarsenical dye reactivity for the
cytosolic pool of protein was lower than in neighboring cells
(Figure 7 and Figure S7B). Other cells devoid of inclusion bodies
also had lower biarsenical dye reactivity than neighboring cells,
which raises the possibility that these cells are on track to form-
ing an inclusion (Figure S7B).
DISCUSSION
The development of TC tags as sensors to monitor protein self-
association by TC burial has provided a novel means to distin-
guish between monomers and higher-order oligomers directly
in live cells. Here we showed that this approach can be used
for FlAsH (green) or ReAsH (red) as sensors of monomers and
with Cerulean (cyan) or Cherry (red) as markers of protein local-
ization. Indeed, the ability to monitor the proportion of mono-
meric relative to oligomeric or microscopically aggregated Htt
in situ will be a powerful toolset for investigating how oligomers
form, how they are trafficked, and how they relate to inclusion
body formation and cellular dysfunction.
A key application of the huntingtin sensors will be in decipher-
ing the precise molecular steps that lead to aggregation and
inclusion formation within living cells. The formation of classic
inclusions, often used as an indicator of overall aggregation, is
a complex cell-mediated process driven by dynein-mediated
retrograde transport of misfolded proteins or microaggregates
(Kopito, 2000). The nature and toxicity of the forms of protein
that precede inclusion formation are largely unknown. How-
ever, different aggregation-prone proteins (e.g., SOD1 mutants,
PABPN1, and pathogenic Httex1) form inclusions with distinct
biophysical properties or cellular localizations, suggesting that
multiple cellular mechanisms exist to process misfolded or
soluble oligomers of proteins (Berger et al., 2006; Matsumoto
et al., 2006). In support of this hypothesis, accessory proteins
in yeast, such as Bmh1 and Cdc48, alter the intracellular distribu-Chemistry & Biology 17,tion of aggregates and/or inclusion formation (Wang et al., 2009).
Moreover, misfolded proteins have been reported to partition
into two distinct quality-control compartments that appear visu-
ally as inclusions—a juxtanuclear compartment where soluble
misfolded proteins are concentrated and a perivacuolar com-
partment for terminally aggregated proteins (Kaganovich et al.,
2008).
In combination, the TC1, TC9, and TC10 markers suggested
that the cytosolic pool of Httex1
46Q had a high proportion of olig-
omers in many cells (50%–70% in Figure 7; Figure S7) express-
ing the pathogenic form of Httex1, even some cells lacking inclu-
sion bodies. Hence, Httex1 aggregation appears to occur evenly
first in the cytosol before trafficking to inclusions. This conclusion
is similar to that reached for a FRET study of another polyQ-con-
taining protein, truncated atrophin-1, whereby pathogenic polyQ
lengths induced more oligomers in the cytosol than their non-
pathogenic counterpart (Takahashi et al., 2008). These findings
highlight a disconnect between visible inclusions and micro-
scopic aggregation and raise the possibility that in disease
cellular activities are compromised by pools of oligomers, sup-
porting the notion that inclusions are a protective response by
cells to sequester diffuse oligomers.
However, while our data are consistent with Httex1 forming
evenly distributed oligomers in the cytosol, we cannot entirely
exclude the possibility that pathogenic Httex1 acquires a novel
monomeric conformation non-permeable to ReAsH binding.
This hypothesis is supported by the finding that monomers of
polyQ fusions to thioredoxin convert from an a-helical to more
compact b sheet conformer before conversion into amyloid-
like fibrils (Nagai et al., 2007). In addition, Httex1 monomers
collapse into a more compact conformation immediately after
cleavage from glutathione S-transferase, which, like maltose-
binding protein, inhibits Htt aggregation (Schaffar et al., 2004).
These and other results suggest that monomeric huntingtin,
while lacking regular secondary structure, does sample a range
of partially compact conformers (Crick et al., 2006; Dougan et al.,
2009).
SIGNIFICANCE
The work is significant for two reasons. First, our study
shows soluble oligomers of mutant Htt, constituting up to
70% of the diffuse huntingtin molecules, which are other-
wise not discernable from monomers by conventional
confocal microscopy, to be evenly distributed in the cytosol
of many cells and are distinct to the visible inclusion bodies.
Hence, small soluble aggregates of Htt are likely to confer
a profound burden on cellular functioning in amanner uncor-
related to inclusion bodies, which have been previously
postulated to play a direct role in Htt toxicity (reviewed in
Hatters, 2008). The second significance is that we describe
a new use of TC tags for reporting on protein self-associa-
tion directly in live cells. The TC tags only bind ReAsH and
FlAsH in monomers due to ReAsH occlusion upon oligomer-
ization, which enables monomers to be quantitatively
demarcated from oligomers in situ in live cells when used
in tandem with a fluorescent protein reporter for localiza-
tion. This methodology, which we refined for Htt, should
be readily adaptable to the other proteins containing polyQ,371–379, April 23, 2010 ª2010 Elsevier Ltd All rights reserved 377
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the eight other diseases caused by polyQ expansions.
Furthermore, we anticipate the fundamental TC burial meth-
odology to be useful in the study of other proteins that
undergo oligomerization as a part of normal cellular biology
or with proteins associated with misfolding- and aggrega-
tion-related disorders, such as Alzheimer’s, Creutzfeldt-
Jakob, and Parkinson’s.
EXPERIMENTAL PROCEDURES
The cloning of the constructs, the expression and purification of recombinant
protein, and the preparation of monomeric Httex1-Cerulean or Cerulean-TC are
described in the Supplemental Experimental Procedures.
Native Slot Blot Assay
Aliquots of TEV-cleaved fusion proteins (2 mM fusion protein) were either
freshly thawed from 80C storage (10 min TEV cleaved samples) or previ-
ously thawed and incubated at 37C for 72 hr under mineral oil (72 hr samples)
prior to analysis. Samples of protein were diluted to a final concentration of
0.8 mM and volume of 100 ml in TNBT buffer [20 mM Tris, 150 mM NaCl,
250 mM BAL (2, 3-dimercapto-1-propanol), and 1 mM tris-carboxyethyl-phos-
phine (TCEP) (pH 7.4)] with or without 1 mM ReAsH (Invitrogen), which was
added from a freshly prepared 2 mM working stock in TNBT. The protein
was incubated for 30 min at room temperature and filtered through a nitrocel-
lulose membrane (0.2 mm pore size) using an SF microfiltration unit (Bio-Rad;
filtration takes less than 2 min). The sample slots were washed twice by
filtration with 100 ml of TNBT buffer and immediately scanned for Cerulean
fluorescence (488 nm excitation and 528 nm emission) and ReAsH fluores-
cence (633 nm excitation and 670 nm emission) with a Typhoon scanner
(GE Biosciences).
Pelleting and ReAsH/FlAsH Binding Assays
Aliquots (200 ml) of TEV-cleaved fusion protein (2 mM) in TNBT were thawed,
incubated under mineral oil at 37C for various times, and divided in half.
One half was centrifuged at 18,000 3 g for 30 min at room temperature, and
the supernatant (50 ml) was removed and added to a black-bottomed fluores-
cence microplate containing 100 ml of TNIT (50 mM Tris, 150 mM NaCl,
12.5 mM imidazole, and 1 mM TCEP). A portion of the uncentrifuged half
(50 ml) was added to the microplate as a control for total protein. The samples
were analyzed for Cerulean fluorescence intensity (434 nm excitation and
475 nm emission; 5 nm bandwidth) with a fluorescence plate reader (Varios-
kan; Thermo Electron Corporation).
For ReAsH/FlAsH reactivity, samples were prepared in the same fashion as
the noncentrifuged protein except that 150 ml TNIT buffer containing 1.33 mM
ReAsH or FlAsH was added to the microplate to provide a final biarsenical dye
concentration of 1 mM when the 50 ml protein was added. After a 20 min incu-
bation at room temperature, ReAsH fluorescence (593 nm excitation and
650 nm emission; 5 nm bandwidth) or FlAsH fluorescence (519 nm excitation
and 540 nm emission; 5 nm bandwidth) was measured with a fluorescence
plate reader (Varioskan).
Transmission Electron Microscopy
Protein samples (2.5 mM) were negatively stained with 1% (w/v) uranyl acetate.
Images were collected on a TF30 electron microscope (FEI) fitted with
a US1000 2k 3 2k CCD camera (Gatan).
Mammalian Cell Culture, ReAsH/FlAsH Staining, and Imaging
Neuro-2a cells were maintained in OptiMem (Invitrogen) supplemented with
10% fetal calf serum, 1 mM glutamine, 100 U/ml penicillin, and 100 mg/ml
streptomycin in a humidified incubator with 5% atmospheric CO2.
For imaging, 8 3 104 cells were plated into a tissue culture-treated 8 well
m-slide (Ibidi). The next day, cells were transfected with the pcDNA3.2 vectors
with Lipofectamine 2000 according to the manufacturer’s instructions (Invitro-
gen). The following day, the medium was replaced and the cells were cultured
for 24 hr, rinsed twice with 300 ml of pre-warmed HBSS buffer (Invitrogen), and378 Chemistry & Biology 17, 371–379, April 23, 2010 ª2010 Elsevierlabeled for 30 min with pre-warmed HBSS containing 1 mM ReAsH or FlAsH
and 10 mM EDT at 37C. The cells were washed in pre-warmed HBSS contain-
ing 250 mM BAL for 15 min, and the solution was replaced with pre-warmed
HBSS.
The cells were imaged live on a TCS SP2 Leica confocal microscope with an
HCX PL APO CS 40.03 1.25 or HCX PL APO lbd.BL 633 1.40 objective, 1 Airy
pinhole, and at a scan rate of 200 Hz with four line averages. Cerulean fluores-
cence was collected at an excitation wavelength of 458 nm and emission
wavelengths of 470–520 nm. GFP fluorescence was measured with an excita-
tion laser of 488 nm and emission wavelengths of 500–538 nm. Cherry fluores-
cence was measured with an excitation laser of 543 nm and emission wave-
lengths of 575–640 nm. ReAsH fluorescence was collected at an excitation
wavelength of 543 nm and emission wavelengths of 580–640 nm. FlAsH fluo-
rescence was collected at an excitation wavelength of 488 nm and emission
wavelengths of 500–540 nm. The PMT voltage was kept constant within
each experiment and varied between some experiments to optimize signal/
noise. Data were obtained in 12 bit format and analyzed with ImageJ. Masks
for filtering Cerulean fluorescence were created with a Cerulean threshold
range from three times the background fluorescence intensity up to, and
excluding, the maximum (i.e., saturated) pixel values. For Cherry, the mask
threshold range was from twice the background fluorescence up to, and
excluding, the maximum pixel value. Data were corrected for background fluo-
rescence before the ReAsH/Cerulean ratio images were calculated. For the
pixel correlation plots, images were converted to 8 bit after data rescaling
(to the same scale for multiple images within each experiment) and analyzed
with the Image Correlator plugin.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.chembiol.2010.03.011.
ACKNOWLEDGMENTS
We thank K. Goldie for performing the electron microscopy experiments. This
work was funded by grants to A.F.H. (National Health and Medical Research
Council program grant 400202 and Career Development Award [Level 2]
509400) and D.M.H. (National Health and Medical Research Council project
grant 566640). D.M.H. is a CR Roper Fellow. S.F. was supported by the
National Institutes of Neurological Disease and Stroke (R01 2NS039074 and
R01 2NS045191), the CHDI Foundation, and the Taube-Koret Center for
Huntington’s Disease Research. J.M. is supported by a predoctoral fellowship
from the Hillbloom Foundation as well as the NIH-NIGMS UCSF Medical
Scientist Training Program.
Received: September 16, 2009
Revised: March 10, 2010
Accepted: March 19, 2010
Published: April 22, 2010
REFERENCES
Adams, S.R., Campbell, R.E., Gross, L.A., Martin, B.R., Walkup, G.K., Yao, Y.,
Llopis, J., and Tsien, R.Y. (2002). New biarsenical ligands and tetracysteine
motifs for protein labeling in vitro and in vivo: synthesis and biological applica-
tions. J. Am. Chem. Soc. 124, 6063–6076.
Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., and Finkbeiner, S.
(2004). Inclusion body formation reduces levels of mutant huntingtin and the
risk of neuronal death. Nature 431, 805–810.
Atwal, R.S., Xia, J., Pinchev, D., Taylor, J., Epand, R.M., and Truant, R.
(2007). Huntingtin has a membrane association signal that can modulate
huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 16,
2600–2615.
Bennett, E.J., Shaler, T.A., Woodman, B., Ryu, K.-Y., Zaitseva, T.S., Becker,
C.H., Bates, G.P., Schulman, H., and Kopito, R.R. (2007). Global changes to
the ubiquitin system in Huntington’s disease. Nature 448, 704–708.Ltd All rights reserved
Chemistry & Biology
Demarcation of Htt Oligomers from MonomersBennett, M.J., Huey-Tubman, K.E., Herr, A.B., West, A.P., Jr., Ross, S.A., and
Bjorkman, P.J. (2002). A linear lattice model for polyglutamine in CAG-expan-
sion diseases. Proc. Natl. Acad. Sci. USA 99, 11634–11639.
Berger, Z., Davies, J.E., Luo, S., Pasco, M.Y., Majoul, I., O’Kane, C.J., and
Rubinsztein, D.C. (2006). Deleterious and protective properties of an aggre-
gate-prone protein with a polyalanine expansion. Hum. Mol. Genet. 15,
453–465.
Brignull, H.R., Morley, J.F., Garcia, S.M., Morimoto, R.I., Kheterpal, I., and
Wetzel, R. (2006). Modeling polyglutamine pathogenesis in C. elegans.
Methods Enzymol. 412, 256.
Chen, S., Berthelier, V., Yang, W., and Wetzel, R. (2001). Polyglutamine aggre-
gation behavior in vitro supports a recruitment mechanism of cytotoxicity.
J. Mol. Biol. 311, 173–182.
Chiti, F., and Dobson, C.M. (2006). Protein misfolding, functional amyloid, and
human disease. Annu. Rev. Biochem. 75, 333–366.
Coleman, B.M., Nisbet, R.M., Han, S., Cappai, R., Hatters, D.M., and Hill, A.F.
(2009). Conformational detection of prion protein with biarsenical labeling and
FlAsH fluorescence. Biochem. Biophys. Res. Commun. 380, 564–568.
Crick, S.L., Jayaraman, M., Frieden, C., Wetzel, R., and Pappu, R.V. (2006).
Fluorescence correlation spectroscopy shows that monomeric polyglutamine
molecules form collapsed structures in aqueous solutions. Proc. Natl. Acad.
Sci. USA 103, 16764–16769.
Dougan, L., Li, J., Badilla, C.L., Berne, B.J., and Fernandez, J.M. (2009). Single
homopolypeptide chains collapse into mechanically rigid conformations. Proc.
Natl. Acad. Sci. USA 106, 12605–12610.
Duennwald, M.L., Jagadish, S., Muchowski, P.J., and Lindquist, S. (2006).
Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc.
Natl. Acad. Sci. USA 103, 11045–11050.
Haass, C., and Selkoe, D.J. (2007). Soluble protein oligomers in neurodegen-
eration: lessons from the Alzheimer’s amyloid b-peptide. Nat. Rev. Mol. Cell
Biol. 8, 101–112.
Hatters, D.M. (2008). Protein misfolding inside cells: the case of huntingtin and
Huntington’s disease. IUBMB Life 60, 724–728.
Ignatova, Z., and Gierasch, L.M. (2004). Monitoring protein stability and aggre-
gation in vivo by real-time fluorescent labeling. Proc. Natl. Acad. Sci. USA 101,
523–528.
Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., Mac-
Donald, M.E., and Zipursky, S.L. (1998). Polyglutamine-expanded human hun-
tingtin transgenes induce degeneration of Drosophila photoreceptor neurons.
Neuron 21, 633.
Kaganovich, D., Kopito, R., and Frydman, J. (2008). Misfolded proteins
partition between two distinct quality control compartments. Nature 454,
1088–1095.
Kim, S., Nollen, E.A.A., Kitagawa, K., Bindokas, V.P., and Morimoto, R.I.
(2002). Polyglutamine protein aggregates are dynamic. Nat. Cell Biol. 4,
826–831.
Kopito, R.R. (2000). Aggresomes, inclusion bodies and protein aggregation.
Trends Cell Biol. 10, 524.
Luedtke, N.W., Dexter, R.J., Fried, D.B., and Schepartz, A. (2007). Surveying
polypeptide and protein domain conformation and association with FlAsH
and ReAsH. Nat. Chem. Biol. 3, 779–784.
MacDonald, M.E., Ambrose, C.M., Duyao, M.P., Myers, R.H., Lin, C., Srinidhi,
L., Barnes, G., Taylor, S.A., James, M., Groot, N., et al. (1993). A novel gene
containing a trinucleotide repeat that is expanded and unstable on Hunting-
ton’s disease chromosomes. Cell 72, 971–983.
Madani, F., Lind, J., Damberg, P., Adams, S.R., Tsien, R.Y., and Gra¨slund,
A.O. (2009). Hairpin structure of a biarsenical-tetracysteine motif determined
by NMR spectroscopy. J. Am. Chem. Soc. 131, 4613–4615.Chemistry & Biology 17,Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hethering-
ton, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W., and Bates, G.P.
(1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to
cause a progressive neurological phenotype in transgenic mice. Cell 87,
493–506.
Matsumoto, G., Kim, S., and Morimoto, R.I. (2006). Huntingtin and mutant
SOD1 form aggregate structures with distinct molecular properties in human
cells. J. Biol. Chem. 281, 4477–4485.
Nagai, Y., Inui, T., Popiel, H.A., Fujikake, N., Hasegawa, K., Urade, Y., Goto, Y.,
Naiki, H., and Toda, T. (2007). A toxic monomeric conformer of the polyglut-
amine protein. Nat. Struct. Mol. Biol. 14, 332–340.
Perutz, M.F., Johnson, T., Suzuki, M., and Finch, J.T. (1994). Glutamine
repeats as polar zippers: their possible role in inherited neurodegenerative
diseases. Proc. Natl. Acad. Sci. USA 91, 5355–5358.
Rizzo, M.A., Springer, G.H., Granada, B., and Piston, D.W. (2004).
An improved cyan fluorescent protein variant useful for FRET. Nat. Biotechnol.
22, 445–449.
Roberti, M.J., Bertoncini, C.W., Klement, R., Jares-Erijman, E.A., and Jovin,
T.M. (2007). Fluorescence imaging of amyloid formation in living cells by a func-
tional, tetracysteine-tagged a-synuclein. Nat. Methods 4, 345–351.
Rockabrand, E., Slepko, N., Pantalone, A., Nukala, V.N., Kazantsev, A., Marsh,
J.L., Sullivan, P.G., Steffan, J.S., Sensi, S.L., and Thompson, L.M. (2007).
The first 17 amino acids of huntingtin modulate its sub-cellular localization,
aggregation and effects on calcium homeostasis. Hum. Mol. Genet. 16, 61–77.
Schaffar, G., Breuer, P., Boteva, R., Behrends, C., Tzvetkov, N., Strippel, N.,
Sakahira, H., Siegers, K., Hayer-Hartl, M., and Hartl, F.U. (2004). Cellular
toxicity of polyglutamine expansion proteins: mechanism of transcription
factor deactivation. Mol. Cell 15, 95–105.
Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R.,
Bates, G.P., Lehrach, H., and Wanker, E.E. (1999). Self-assembly of polyglut-
amine-containing huntingtin fragments into amyloid-like fibrils: implications for
Huntington’s disease pathology. Proc. Natl. Acad. Sci. USA 96, 4604–4609.
Steffan, J.S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L.C., Slepko,
N., Illes, K., Lukacsovich, T., Zhu, Y.-Z., Cattaneo, E., et al. (2004). SUMO
modification of huntingtin and Huntington’s disease pathology. Science 304,
100–104.
Takahashi, T., Kikuchi, S., Katada, S., Nagai, Y., Nishizawa, M., and Onodera,
O. (2008). Soluble polyglutamine oligomers formed prior to inclusion body
formation are cytotoxic. Hum. Mol. Genet. 17, 345–356.
Thakur, A.K., and Wetzel, R. (2002). Mutational analysis of the structural
organization of polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 99,
17014–17019.
Thakur, A.K., Jayaraman, M., Mishra, R., Thakur, M., Chellgren, V.M., Byeon,
I.-J., Anjum, D.H., Kodali, R., Creamer, T.P., Conway, J.F., Gronenborn, A.M.,
and Wetzel, R. (2009). Polyglutamine disruption of the huntingtin exon 1 N
terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol.
16, 380–389.
Wang, Y., Meriin, A.B., Zaarur, N., Romanova, N.V., Chernoff, Y.O., Costello,
C.E., and Sherman, M.Y. (2009). Abnormal proteins can form aggresome in
yeast: aggresome-targeting signals and components of the machinery. FASEB
J. 23, 451–463.
Zoghbi, H.Y., and Orr, H.T. (2000). Glutamine repeats and neurodegeneration.
Annu. Rev. Neurosci. 23, 217–247.
Zuhlke, C., Rless, O., Bockel, B., Lange, H., and Thies, U. (1993). Mitotic
stability and meiotic variability of the (CAG)N repeat in the Huntington disease
gene. Hum. Mol. Genet. 2, 2063–2067.371–379, April 23, 2010 ª2010 Elsevier Ltd All rights reserved 379
